Thyrocare Q2 FY27 earnings call on Oct 29, 2026

Board & Shareholder Meetings View source PDF Explain this filing

THYROCARE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.9%Reaction day

₹475.50

prior close

₹467.25

announcement price

After-mkt

timing

Nifty Microcap 250market-2.3%+0.5% vs market

Healthcare Service Provider peers, median of 26sector-0.5%-1.4% vs sector

On the reaction day the stock moved 0.5 pts more than Nifty Microcap 250 and 1.4 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-2.0

10m

-1.2

15m

-0.8

30m

-1.2

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.9-2.3+0.5-0.5-1.4

Next day

-0.1-1.9+1.8-0.2+0.1

+4.0-0.2+4.3+1.3+2.8

+4.0pendingpending-0.6+4.6

—————

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Healthcare Service Provider peers, median of 26Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Thyrocare Technologies has scheduled an earnings conference call for analysts and investors on Thursday, October 29, 2026 at 6:00 PM IST to discuss its unaudited financial results for Q2 and half year ended September 30, 2026. Senior management including MD and CEO Rahul Guha, COO Dr. Ramesh Kinha, CFO Vikram Gupta, CCO Rajdeep Panwar, and DGM Strategy and IR Prinesh Parikh will attend. Dial-in and webcast details shared in the invite.

Likely market impact

Routine disclosure. No business impact; investors can join the call to hear about Q2 and H1 FY27 results.